We are live on ! Find out more
KOSP

K O S PHARMACEUTICALS INC
KOSP

Delisted

KOSP was delisted on the 14th of December, 2006.

Back to rankings

1 hedge funds and large institutions have $3.95M invested in K O S PHARMACEUTICALS INC in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SHFA
SS&H Financial Advisors
Michigan
+$3.95M

Top Sellers

No sellers this quarter

KOSP Hedge Fund Activity: Q3 2022 in Review

1 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q3 2022, worth a combined $3.95M.

Buyers outnumbered sellers: 1 fund opened new KOSP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SS&H Financial Advisors, opening a new position worth an estimated $3.95M.

  • 1 institutional investor held K O S PHARMACEUTICALS INC (KOSP) as of Q3 2022, up from 0 in Q2 2022.
  • Funds reported $3.95M of K O S PHARMACEUTICALS INC stock for Q3 2022.
  • 1 fund opened new K O S PHARMACEUTICALS INC positions in Q3 2022 and 0 closed out, a net change of +1 holder.
  • The largest K O S PHARMACEUTICALS INC buyer in Q3 2022 was SS&H Financial Advisors, an estimated $3.95M added.

Based on aggregated 13F filings for Q3 2022.